Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
All travel into Uk will require a test.
https://www.bbc.co.uk/news/live/world-55673006
RNS Number : 5638L
Novacyt S.A.
13 January 2021
Novacyt S.A.
("Novacyt" or the "Company")
Holdings in Company
Paris, France and Camberley, UK - 13 January 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 12 January 2021 that, as at 11 January 2021 BlackRock Inc.'s holding in the Company on a voting and capital basis is 2.95% (2,085,368 shares).
For further information, please refer to www.novacyt.com or contact:
Contacts
Novacyt SA
Graham Mullis, Chief Executive Officer
James McCarthy, Chief Financial Officer
+44 (0)1276 600081
Just got off the phone with a friend whom is working at the Warner studios near NW london.
He is working on a big film up there and they have a PCR test twice a week. Close to 2000 employees up at the studios. I asked who was supplying the tests and he said future medical.
Can someone look into that who has a better knowledge of digging
cyt S.A.
05 January 2021
Novacyt S.A.
("Novacyt" or the "Company" or the "Group")
Executive Management and Proposed Board Changes
Paris, France and Camberley, UK - 5 January 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that James McCarthy has been appointed as Chief Financial Officer (CFO), whilst Anthony Dyer has taken on a new role as Chief Corporate Development Officer (CCDO). Both appointments are with immediate effect.
Mr McCarthy will become a Board Director of the Company, subject to shareholder approval, at the AGM. Anthony Dyer will remain a Board Director until James McCarthy is elected to the Board.
James has held a number of senior positions in major listed and private equity-backed businesses. Most recently he was CFO of Flint Group, a $2.5bn revenue, PE backed business with 7,900 staff and 180 sites across 40 countries. Previously, he was CFO of Brambles Plc's EMEA CHEP business before being promoted to President of CHEP's European team. Brambles Plc is an Australian-based, ASX listed business with a market capitalisation of AU$16bn. James trained as an accountant with Dairygold, receiving his ACCA qualification in 1988, before going on to work for a range of businesses including Unilever and ICI Plc.
Graham Mullis, Chief Executive Officer of Novacyt, commented:
"On behalf of the Board, I am pleased to welcome James to the role of CFO. He joins Novacyt having held senior finance positions at a number of large blue-chip manufacturing organisations. His considerable financial, commercial and Board experience will be invaluable as Novacyt embarks on its next stage of growth.
"I would also like to take this opportunity to thank Anthony personally for the key role he has played in helping transform Novacyt into a leading diagnostics developer and manufacturer. His new, important role reflects the Company's growth strategy, which includes selective potential M&A to supplement organic growth initiatives. I look forward to working with Anthony and James as part of an expanded executive team."
The information required by Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies in relation to the appointment of James Martin McCarthy (age 54) is as follows:
Current directorships
Past directorships held within last five years
Energy Transition Forum Limited
CHEP Israel Limited
Focus4Value Limited
Xeikon NV.
XBC BV
Mr McCarthy holds 10,000 ordinary shares in the Company. There are no other disclosures required in accordance with Schedule 2(g) of the AIM Rules.
“Gold standard”
From the beeb.
Travel will also be available to people carrying out essential trips, including health staff fighting against Covid-19, those who provide international transport of goods, fishing crew and bus or train drivers.
But in order to travel, they will need to have received a negative PCR test result less than 72 hours before departure.
"French nationals, people living in France and those with a legitimate reason will have to be carrying a negative test," French transport minister Jean-Baptiste Djebarri said.
The PCR (polymerase chain reaction) Covid test is regarded as the "gold standard" by epidemiologists, but takes up to a day or longer to produce a result because the sample has to be sent off to a laboratory.